AngioDynamics, Inc.
ANGO · NASDAQ
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Market Cap | $422 | $418 | $380 | $284 |
| - Cash | $39 | $56 | $45 | $54 |
| + Debt | $0 | $0 | $5 | $5 |
| Enterprise Value | $384 | $362 | $340 | $234 |
| Revenue | $76 | $80 | $72 | $73 |
| % Growth | -5.5% | 11.3% | -1.2% | – |
| Gross Profit | $42 | $42 | $39 | $40 |
| % Margin | 55.3% | 52.7% | 54% | 54.8% |
| EBITDA | -$5 | $2 | -$0 | $2 |
| % Margin | -6.4% | 2.7% | -0.5% | 2.5% |
| Net Income | -$11 | -$6 | -$4 | -$11 |
| % Margin | -14.4% | -7.5% | -6.1% | -14.7% |
| EPS Diluted | -0.26 | -0.15 | -0.11 | -0.26 |
| % Growth | -73.3% | -36.4% | 57.7% | – |
| Operating Cash Flow | -$16 | $19 | -$13 | $2 |
| Capital Expenditures | -$1 | -$1 | -$2 | -$1 |
| Free Cash Flow | -$17 | $18 | -$15 | $2 |